CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy

Glioblastoma (GB) is the most common and aggressive primary brain tumor in adults and currently incurable. Despite multimodal treatment regimens, median survival in unselected patient cohorts is <1 year, and recurrence remains almost inevitable. Escape from immune surveillance is thought to contr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Autores principales: Burger, Michael C., Zhang, Congcong, Harter, Patrick N., Romanski, Annette, Strassheimer, Florian, Senft, Christian, Tonn, Torsten, Steinbach, Joachim P., Wels, Winfried S.
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6868035/
https://ncbi.nlm.nih.gov/pubmed/31798595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02683
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares